Heat Biologics
Heat Biologics CEO to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29th
September 15, 2021 07:30 ET | Heat Biologics
DURHAM, N.C., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (Nasdaq: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune...
Heat Biologics
Heat Biologics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
September 09, 2021 08:30 ET | Heat Biologics
DURHAM, N.C., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (Nasdaq: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune...
Heat Biologics
Heat Biologics to Provide Corporate Update
August 30, 2021 07:30 ET | Heat Biologics
DURHAM, N.C., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate...
Heat Biologics
Heat Biologics Unveils Skunkworx Bio, New Drug Discovery Subsidiary
August 26, 2021 08:00 ET | Heat Biologics
DURHAM, N.C., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate...
Heat Biologics
Heat Biologics Announces Addition of Former US Senator Mark Pryor to Biothreat Advisory Board
August 23, 2021 08:00 ET | Heat Biologics
DURHAM, N.C., Aug. 23, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate...
Heat Biologics
Heat Biologics Announces New Additions to Biothreat Advisory Board
August 19, 2021 09:00 ET | Heat Biologics
Former Assistant Secretary of Defense for Nuclear, Chemical & Biological Defense Programs, Andrew C. Weber Expert on Chemical and Biological Weapons, Dr. Gregory Koblentz DURHAM, N.C., Aug. 19,...
Heat Biologics
Heat Biologics Announces Formation of Biothreat Advisory Board
August 18, 2021 08:00 ET | Heat Biologics
DURHAM, N.C., Aug. 18, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate...
Heat Biologics
Heat Biologics Provides Second Quarter 2021 Business Update
August 11, 2021 16:05 ET | Heat Biologics
DURHAM, N.C., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the...
Heat Biologics
Heat Biologics Announces Groundbreaking for New San Antonio Facility
August 09, 2021 07:30 ET | Heat Biologics
DURHAM, N.C., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate...
Heat Biologics
Heat Biologics Joins Russell Microcap® Index
June 28, 2021 07:30 ET | Heat Biologics
DURHAM, N.C., June 28, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (Nasdaq: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune...